Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
31%
OVERLAP
BY WEIGHT
11
# OF OVERLAPPING
HOLDINGS
HRTS
42
HOLDINGS
26%
ALSO IN THNR
THNR
19
HOLDINGS
58%
ALSO IN HRTS
SECTOR DRIFT (HRTS minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
| ELI LILLY & CO | 10.2% | 12.5% | 10.2% | |
| ASTRAZENECA PLC | 4.4% | 5.0% | 4.4% | |
| MERCK & CO. INC. | 4.2% | 5.9% | 4.2% | |
| ABBVIE INC | 2.9% | 4.8% | 2.9% | |
| AMGEN INC | 2.1% | 7.7% | 2.1% | |
HRTS Overweight Relative to THNR
| ROCHE HOLDINGS LTD-SPONS ADR | 5.4% | |
| JOHNSON & JOHNSON | 4.8% | |
| THERMO FISHER SCIENTIFIC INC | 4.1% | |
| GILEAD SCIENCES INC | 3.8% | |
| UNITEDHEALTH GROUP INC | 3.7% | |
| NOVARTIS AG | 3.3% | |
| ABBOTT LABORATORIES | 3.3% | |
| DANAHER CORP | 3.0% | |
| MEDTRONIC PLC | 3.0% | |
| VERTEX PHARMACEUTICALS INC | 2.9% |
HRTS Underweight Relative to THNR
| NOVO-NORDISK A/S-SPONS ADR | -11.4% | |
| SHIONOGI & CO LTD | -5.9% | |
| AMGEN INC | -5.6% | |
| ROCHE HOLDING LTD | -5.5% | |
| PFIZER INC | -5.1% | |
| CHUGAI PHARMACEUTICAL CO LTD | -4.8% | |
| REGENERON PHARMACEUTICALS | -4.6% | |
| INNOVENT BIOLOGICS, INC. | -4.4% | |
| CHINA PHARMACEUTICAL GROUP | -4.3% | |
| ARROWHEAD PHARMACEUTICALS, INC. | -2.7% |